Literature DB >> 26339794

Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.

Julia C Frei1, Margaret Kielian2, Jonathan R Lai3.   

Abstract

Here we investigated the binding of Dengue virus envelope glycoprotein domain III (DIII) by two broadly neutralizing antibodies (bNAbs), 4E11 and 4E5A. There are four serotypes of Dengue virus (DENV-1 to -4), whose DIII sequences vary by up to 49%. We used combinatorial alanine scanning mutagenesis, a phage display approach, to map functional epitopes (those residues that contribute most significantly to the energetics of antibody-antigen interaction) on these four serotypes. Our results showed that 4E11, which binds strongly to DENV-1, -2, and -3, and moderately to DENV-4, recognized a common conserved core functional epitope involving DIII residues K310, L/I387, L389, and W391. There were also unique recognition features for each serotype, suggesting that 4E11 has flexible recognition requirements. Similar scanning studies for the related bNAb 4E5A, which binds more tightly to DENV-4, identified broader functional epitopes on DENV-1. These results provide useful information for immunogen and therapeutic antibody design.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Broadly neutralizing antibodies; Combinatorial scanning mutagenesis; Dengue virus; Flavivirus; phage display

Mesh:

Substances:

Year:  2015        PMID: 26339794      PMCID: PMC4619145          DOI: 10.1016/j.virol.2015.08.011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  64 in total

1.  Rapid mapping of protein functional epitopes by combinatorial alanine scanning.

Authors:  G A Weiss; C K Watanabe; A Zhong; A Goddard; S S Sidhu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  A comparative analysis of the immunological evolution of antibody 28B4.

Authors:  J Yin; E C Mundorff; P L Yang; K U Wendt; D Hanway; R C Stevens; P G Schultz
Journal:  Biochemistry       Date:  2001-09-11       Impact factor: 3.162

3.  Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.

Authors:  W D Crill; J T Roehrig
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.

Authors:  Richard J Kuhn; Wei Zhang; Michael G Rossmann; Sergei V Pletnev; Jeroen Corver; Edith Lenches; Christopher T Jones; Suchetana Mukhopadhyay; Paul R Chipman; Ellen G Strauss; Timothy S Baker; James H Strauss
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

5.  Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.

Authors:  Olesia Lisova; Laurent Belkadi; Hugues Bedouelle
Journal:  J Mol Recognit       Date:  2014-04       Impact factor: 2.137

6.  Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

Authors:  Luke N Robinson; Kannan Tharakaraman; Kirk J Rowley; Vivian V Costa; Kuan Rong Chan; Yee Hwa Wong; Li Ching Ong; Hwee Cheng Tan; Tyree Koch; David Cain; Rama Kirloskar; Karthik Viswanathan; Chong Wai Liew; Hamid Tissire; Boopathy Ramakrishnan; James R Myette; Gregory J Babcock; V Sasisekharan; Sylvie Alonso; Jianzhu Chen; Julien Lescar; Zachary Shriver; Eng Eong Ooi; Ram Sasisekharan
Journal:  Cell       Date:  2015-07-16       Impact factor: 41.582

7.  Recognition determinants of broadly neutralizing human antibodies against dengue viruses.

Authors:  Alexander Rouvinski; Pablo Guardado-Calvo; Giovanna Barba-Spaeth; Stéphane Duquerroy; Marie-Christine Vaney; Carlos M Kikuti; M Erika Navarro Sanchez; Wanwisa Dejnirattisai; Wiyada Wongwiwat; Ahmed Haouz; Christine Girard-Blanc; Stéphane Petres; William E Shepard; Philippe Desprès; Fernando Arenzana-Seisdedos; Philippe Dussart; Juthathip Mongkolsapaya; Gavin R Screaton; Félix A Rey
Journal:  Nature       Date:  2015-01-12       Impact factor: 49.962

8.  High affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticity.

Authors:  Jenny Bostrom; Lauric Haber; Patrick Koenig; Robert F Kelley; Germaine Fuh
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

9.  Antibody internalization studied using a novel IgG binding toxin fusion.

Authors:  Yariv Mazor; Itay Barnea; Iafa Keydar; Itai Benhar
Journal:  J Immunol Methods       Date:  2007-02-06       Impact factor: 2.287

10.  A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.

Authors:  Wanwisa Dejnirattisai; Wiyada Wongwiwat; Sunpetchuda Supasa; Xiaokang Zhang; Xinghong Dai; Alexander Rouvinski; Amonrat Jumnainsong; Carolyn Edwards; Nguyen Than Ha Quyen; Thaneeya Duangchinda; Jonathan M Grimes; Wen-Yang Tsai; Chih-Yun Lai; Wei-Kung Wang; Prida Malasit; Jeremy Farrar; Cameron P Simmons; Z Hong Zhou; Felix A Rey; Juthathip Mongkolsapaya; Gavin R Screaton
Journal:  Nat Immunol       Date:  2014-12-15       Impact factor: 25.606

View more
  10 in total

1.  Suppressive effect of dengue virus envelope protein domain III on megakaryopoiesis.

Authors:  Guan-Ling Lin; Hsin-Hou Chang; Te-Sheng Lien; Po-Kong Chen; Hao Chan; Mei-Tzu Su; Chi-Yuan Liao; Der-Shan Sun
Journal:  Virulence       Date:  2017-07-20       Impact factor: 5.882

2.  Preface.

Authors:  V L Pecoraro
Journal:  Methods Enzymol       Date:  2016       Impact factor: 1.600

3.  Protein and Antibody Engineering by Phage Display.

Authors:  J C Frei; J R Lai
Journal:  Methods Enzymol       Date:  2016-06-29       Impact factor: 1.600

4.  Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.

Authors:  Julia C Frei; Ariel S Wirchnianski; Jennifer Govero; Olivia Vergnolle; Kimberly A Dowd; Theodore C Pierson; Margaret Kielian; Mark E Girvin; Michael S Diamond; Jonathan R Lai
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

5.  Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.

Authors:  Michal Juraska; Craig A Magaret; Jason Shao; Lindsay N Carpp; Andrew J Fiore-Gartland; David Benkeser; Yves Girerd-Chambaz; Edith Langevin; Carina Frago; Bruno Guy; Nicholas Jackson; Kien Duong Thi Hue; Cameron P Simmons; Paul T Edlefsen; Peter B Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

6.  Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo.

Authors:  George I Georgiev; Ryan J Malonis; Ariel S Wirchnianski; Alex W Wessel; Helen S Jung; Sean M Cahill; Elisabeth K Nyakatura; Olivia Vergnolle; Kimberly A Dowd; David Cowburn; Theodore C Pierson; Michael S Diamond; Jonathan R Lai
Journal:  Cell Chem Biol       Date:  2022-02-28       Impact factor: 9.039

7.  Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.

Authors:  J L Slon Campos; S Marchese; J Rana; M Mossenta; M Poggianella; M Bestagno; O R Burrone
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

8.  Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513.

Authors:  Yee Hwa Wong; Akshita Kumar; Chong Wai Liew; Kannan Tharakaraman; Kannan Srinivasaraghavan; Ram Sasisekharan; Chandra Verma; Julien Lescar
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

9.  Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection.

Authors:  Srivamshi Pittala; Kenneth Bagley; Jennifer A Schwartz; Eric P Brown; Joshua A Weiner; Ilia J Prado; Wenlei Zhang; Rong Xu; Ayuko Ota-Setlik; Ranajit Pal; Xiaoying Shen; Charles Beck; Guido Ferrari; George K Lewis; Celia C LaBranche; David C Montefiori; Georgia D Tomaras; Galit Alter; Mario Roederer; Timothy R Fouts; Margaret E Ackerman; Chris Bailey-Kellogg
Journal:  Mol Syst Biol       Date:  2019-05-02       Impact factor: 11.429

10.  Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.

Authors:  Babu Ramanathan; Chit Laa Poh; Kristin Kirk; William John Hannan McBride; John Aaskov; Lara Grollo
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.